Jefferies Initiates Coverage on Medgenics Inc to Buy

Jefferies Initiates Coverage on Medgenics Inc(NYSEMKT:MDGN). The shares have been rated Buy. The rating by Jefferies was issued on Sep 23, 2016.

Medgenics Inc (MDGN) made into the market gainers list on Tuesdays trading session with the shares advancing 0.54% or 0.03 points. Due to strong positive momentum, the stock ended at $5.63, which is also near the day’s high of $5.71. The stock began the session at $5.6331 and the volume stood at 1,03,738 shares. The 52-week high of the shares is $8.5 and the 52 week low is $3.0901. The company has a current market capitalization of $209 M and it has 3,70,78,343 shares in outstanding.

Medgenics Inc(MDGN) last announced its earnings results on Aug 4, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $0.00. Analysts had an estimated revenue of $750.00K. Earnings per share were $-0.35. Analysts had estimated an EPS of $-0.30.

Several Insider Transactions has been reported to the SEC. On Oct 8, 2015, Sol J Barer (director) purchased 153,846 shares at $6.50 per share price.Also, On Oct 8, 2015, Michael F Cola (CEO) purchased 38,460 shares at $6.50 per share price.On Oct 8, 2015, Garry Arthur Neil (Chief Scientific Officer) purchased 15,384 shares at $6.50 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Medgenics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medgenics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.